Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Necmi Eren

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Echocardiography (Mount Kisco, N.Y.)|December 31, 2013
Epicardial adipose tissue thickness in hemodialysis patientsBurak Altun, Hakan Tasolar, Necmi Eren, et al.
Nephron|January 5, 2023
Humoral Response to BNT162b2 and CoronaVac in Patients Undergoing Maintenance Hemodialysis: A Multicenter Prospective Cohort StudySafak Mirioglu, Rumeyza Kazancioglu, Egemen Cebeci, et al.
BMC Nephrology|May 26, 2025
The relationship between multiple plasma biomarker levels and renal disease activity in Fabry diseaseSeyda Gul Ozcan, Necmi Eren, Mevlut Tamer Dincer, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 26, 2022
Relationship between disease awareness and severity of kidney disease in autosomal dominant polycystic kidney disease patientsEge Dogan, Necmi Eren, Seyda Gul Ozcan, et al.
Kidney International|October 21, 2022
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathyJonathan Barratt, Richard Lafayette, Jens Kristensen, et al.
Kidney & Blood Pressure Research|October 27, 2020
Renal Tubular Acidosis in Patients with Systemic Lupus ErythematosusNecmi Eren, Ozkan Gungor, Feyza Nur Sarisik, et al.
Seminars in Dialysis|July 21, 2020
Can vasohibin-1, an endothelium-derived angiogenesis inhibitor, be a marker of endothelial dysfunction in hemodialysis patients?Orcun Altunoren, Murat Kerkutluoglu, Feyza Nur Sarısık, et al.
Lancet (London, England)|August 17, 2023
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trialRichard Lafayette, Jens Kristensen, Andrew Stone, et al.
Blood Purification|September 13, 2021
How Dialysis Patients Cope with a Curfew? A Comparison of Psychological Status between Hemodialysis and Peritoneal Dialysis Patients During the COVID-19 PandemicCebrail Karaca, Necmi Eren, Mevlut Tamer Dincer, et al.
Turkish Journal of Medical Sciences|March 22, 2023
A comparison of antibody response in kidney transplant recipients and healthcare workers who had PCR-confirmed COVID-19 infectionMevlüt Tamer Dincer, Necmi Eren, Ahmet Murt, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Echocardiography (Mount Kisco, N.Y.)|December 31, 2013
Epicardial adipose tissue thickness in hemodialysis patientsBurak Altun, Hakan Tasolar, Necmi Eren, et al.
Nephron|January 5, 2023
Humoral Response to BNT162b2 and CoronaVac in Patients Undergoing Maintenance Hemodialysis: A Multicenter Prospective Cohort StudySafak Mirioglu, Rumeyza Kazancioglu, Egemen Cebeci, et al.
BMC Nephrology|May 26, 2025
The relationship between multiple plasma biomarker levels and renal disease activity in Fabry diseaseSeyda Gul Ozcan, Necmi Eren, Mevlut Tamer Dincer, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 26, 2022
Relationship between disease awareness and severity of kidney disease in autosomal dominant polycystic kidney disease patientsEge Dogan, Necmi Eren, Seyda Gul Ozcan, et al.
Kidney International|October 21, 2022
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathyJonathan Barratt, Richard Lafayette, Jens Kristensen, et al.
Kidney & Blood Pressure Research|October 27, 2020
Renal Tubular Acidosis in Patients with Systemic Lupus ErythematosusNecmi Eren, Ozkan Gungor, Feyza Nur Sarisik, et al.
Seminars in Dialysis|July 21, 2020
Can vasohibin-1, an endothelium-derived angiogenesis inhibitor, be a marker of endothelial dysfunction in hemodialysis patients?Orcun Altunoren, Murat Kerkutluoglu, Feyza Nur Sarısık, et al.
Lancet (London, England)|August 17, 2023
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trialRichard Lafayette, Jens Kristensen, Andrew Stone, et al.
Blood Purification|September 13, 2021
How Dialysis Patients Cope with a Curfew? A Comparison of Psychological Status between Hemodialysis and Peritoneal Dialysis Patients During the COVID-19 PandemicCebrail Karaca, Necmi Eren, Mevlut Tamer Dincer, et al.
Turkish Journal of Medical Sciences|March 22, 2023
A comparison of antibody response in kidney transplant recipients and healthcare workers who had PCR-confirmed COVID-19 infectionMevlüt Tamer Dincer, Necmi Eren, Ahmet Murt, et al.
Pageof 7